Skip to main content

Year: 2023

electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology

ROCKAWAY, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Trademark Office has issued a patent related to a system for stimulating a nerve target in the head or neck of a patient for treatment of various disorders, such as primary headache. U.S. Patent No. 11,839,764 entitled “Systems and Methods for Treating a Medical Condition with an Electrical Stimulation Treatment Regimen” was issued on December 12, 2023, and is generally related to a system including a downloadable software program on, for example, a mobile device, that is configured to control a parameter of the electrical impulses delivered by a stimulator for targeting nerves in the head or neck of a patient to treat various disorders such...

Continue reading

LatAm Logistic Properties S.A. and two Announce Public Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination

ZEPHYR COVE, Nev. and SAN JOSÉ, Costa Rica, Dec. 12, 2023 (GLOBE NEWSWIRE) — two (NYSE: TWOA) (“TWOA”), a special purpose acquisition company, and LatAm Logistic Properties S.A. (d/b/a LatAm Logistic Properties) (“LLP”), a leading developer, owner, and manager of institutional quality, class A industrial and logistics real estate in Central and South America, announced today the public filing of a registration statement on Form F-4 with the U.S. Securities and Exchange Commission (the “SEC”). The registration statement was filed by Logistic Properties of the Americas, a newly-formed holding company (“Pubco”), in connection with LLP and TWOA’s proposed business combination. On August 15, 2023, LLP and TWOA entered into a definitive business combination agreement that would result in LLP becoming a publicly traded company. As a result...

Continue reading

Baker Hughes Announces Date for Fourth Quarter and Full-year 2023 Earnings Release and Webcast

HOUSTON and LONDON, Dec. 12, 2023 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR) will announce the results of the fourth quarter and full year ending Dec. 31, 2023, via press release at 5 p.m. Eastern Time (4 p.m. Central Time) on Tuesday, Jan. 23, 2024. A webcast to discuss the results will be held Wednesday, Jan. 24, 2024, at 9:30 a.m. Eastern Time (8:30 a.m. Central Time). To access the webcast, listeners should visit the Baker Hughes website at: investors.bakerhughes.com. An archived version will be available on the website following the webcast. About Baker Hughes:Baker Hughes (NASDAQ: BKR) is an energy technology company that provides solutions to energy and industrial customers worldwide. Built on a century of experience and conducting business in over 120 countries, our innovative technologies and services are taking energy...

Continue reading

3D Printing Filament Market Size Worth USD 14.07 Billion in 2032 | Emergen Research

Increasing use of 3D printing filaments in the in automotive and aerospace industries and rising demand for Three Dimensional printing filaments for mass communication are key factors driving market revenue growth Vancouver, Dec. 12, 2023 (GLOBE NEWSWIRE) — The global Three Dimensional (3D) printing filament market is experiencing a robust growth trajectory, with a market size of USD 1.23 billion in 2022 and an anticipated rapid revenue Compound Annual Growth Rate (CAGR) of 27.6% during the forecast period. Key drivers include the increasing use of 3D printing filaments in the automotive and aerospace industries, a rising demand for mass communication applications, and the myriad benefits offered by 3D printing technology, such as reduced operating time and lower manufacturing costs. Governments worldwide are actively supporting...

Continue reading

Clinical Biomarkers Market Size to Reach USD 63.04 Billion in 2032 | Emergen Research

Increasing usage of biomarkers in cancer treatment and increasing government initiatives to minimize healthcare burden are factors driving global clinical biomarkers market growth Vancouver, Dec. 12, 2023 (GLOBE NEWSWIRE) — The global clinical biomarkers market is expected to reach a market size of USD 63.04 billion at a steady CAGR of 10.2% in 2032, according to latest analysis by Emergen Research. This steady revenue growth of the market can be attributed to increasing prevalence of obesity and diabetes among the growing population. Increasing prevalence of chronic diseases globally due to sedentary lifestyle, unhealthy diet, rising tobacco use, exposure to secondhand smoke, lack of physical activity, and excessive alcohol are some key factors driving growth of the clinical biomarkers market, and the trend is expected to continue...

Continue reading

Global Deep Brain Stimulation Market Size to Reach USD 4.27 Billion in 2032 | Emergen Research

Technological advancements in Deep Brain Stimulation (DBS), significant prevalence of Parkinson’s disease, dystonia and epilepsy, together with rising demand for painless and wireless rechargeable systems are expected to fuel the market growth Vancouver, Dec. 12, 2023 (GLOBE NEWSWIRE) — The global Deep Brain Stimulation (DBS) market, valued at USD 1.70 Billion in 2022, is projected to witness a robust revenue Compound Annual Growth Rate (CAGR) of 9.6% during the forecast period. A surge in Parkinson’s Disease (PD) diagnoses, particularly among the elderly, and increased life expectancy contribute to this growth. The prevalence of PD has witnessed a 50% rise in the U.S. alone, reaching over 90,000 cases in 2022. As a primary treatment for conditions like Parkinson’s disease and epilepsy, there is a soaring demand for...

Continue reading

DAVIDsTEA Reports Financial Results for Third Quarter of Fiscal 2023

Sales of $12.1 million compared to $16.2 million in third quarter of 2022 SG&A expenses managed downwards 19.3% year-over-year to $8.3 million Net loss amounted to $3.7 million compared to $4.7 million in third quarter of 2022 Cash and working capital positions totaled $11.7 million and $20.1 million, respectively Start of U.S. wholesale market expansion with release of four tea sachet flavours at 150 Stop & Shop supermarketsMONTREAL, Dec. 12, 2023 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (TSX-Venture: DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North America, announced today its third quarter results for the period ended October 28, 2023. “Although sales remained muted in the third quarter of 2023 due to a persistent challenging economic environment, we have launched a series of go-to-market initiatives...

Continue reading

Abacus Life Announces $15 Million Stock Repurchase Program

ORLANDO, Fla., Dec. 12, 2023 (GLOBE NEWSWIRE) — Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, announced today that its Board of Directors has authorized a new stock repurchase program of up to $15 million of the Company’s outstanding common stock over a period of up to 18 months. “We are pleased that our Board of Directors has authorized a stock repurchase program, which reflects our Board’s continued confidence in our proven business model and wealth of opportunities, as well as the strength of our balance sheet,“ stated Jay Jackson, Chairman and Chief Executive Officer of Abacus. “We believe our expert team, wealth of data and innovative technology continue to...

Continue reading

Aromatics Market Size Worth USD 429.78 Billion in 2032 | Emergen Research

Rising demand for aromatics from the automotive sector and paints & coatings industry and increasing need for aromatics rings in medicinal chemistry are key factors driving Aromatics market revenue growth Vancouver, Dec. 12, 2023 (GLOBE NEWSWIRE) — The global aromatics market size was USD 260.20 billion in 2022 and is expected to register a rapid revenue CAGR of 5.8% during the forecast period. The global aromatics market is witnessing a transformative shift, driven by the automotive industry’s increasing preference for aromatics-derived products. These materials, renowned for their lightweight properties, contribute to substantial fuel efficiency gains. A recent study reveals that aromatics can reduce fuel consumption by 750 liters over a vehicle’s lifespan, covering 150,000 kilometers—an advantageous prospect...

Continue reading

Expanded Polystyrene Market Size Worth USD 26.23 Billion in 2032 | Emergen Research

Rapid growth of construction and packaging industries in developing countries and rising use of EPS products in numerous applications are major factors driving Expanded Polystyrene (EPS) market revenue growth Vancouver, Dec. 12, 2023 (GLOBE NEWSWIRE) — The global Expanded Polystyrene (EPS) market size was USD 11.03 billion in 2022 and is expected to register a rapid revenue CAGR of 9.1% during the forecast period. The global Expanded Polystyrene (EPS) market is experiencing a surge in demand, driven by its lightweight, affordable pricing, and excellent insulating capabilities. EPS foam, widely used in packaging for electronics, appliances, and food & beverages, protects against transit damage with its shock-absorbing properties. Moreover, the building and construction sector is witnessing increased demand for EPS due to its...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.